Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
1,079,784,035
-
Total 13F shares
-
124,100,473
-
Share change
-
+44,484,180
-
Total reported value
-
$327,790,828
-
Put/Call ratio
-
126%
-
Price per share
-
$2.64
-
Number of holders
-
236
-
Value change
-
+$117,120,264
-
Number of buys
-
162
-
Number of sells
-
59
Institutional Holders of ImmunityBio, Inc. - Common Stock, par value $0.0001 per share (IBRX) as of Q2 2025
As of 30 Jun 2025,
ImmunityBio, Inc. - Common Stock, par value $0.0001 per share (IBRX) was held by
236 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
124,100,473 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock, Inc., BANK OF AMERICA CORP /DE/, ARMISTICE CAPITAL, LLC, JANE STREET GROUP, LLC, STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, Woodline Partners LP, MILLENNIUM MANAGEMENT LLC, and AlphaCore Capital LLC.
This page lists
237
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.